The hurdles on the path toward a fair, global distribution of the COVID-19 vaccine are economic, technical, political, and moral. The difficulty of vaccine rollouts, even in the world’s richest countries, demonstrates what a daunting task it is to quickly get the inoculations into the arms of as many people as possible. [1]
